Abstract
The present study describes the Bi (III) chloride catalyzed transformation of 4'-hydroxy-3',5'-dinitrochalcones into the corresponding benzoxazepines followed by sequential Michael addition using Bi (III) oxychloride as a procatalyst efficiently.
Keywords: Benzoxazepines, pro-catalyst, chalcones, Michael addition.
Letters in Organic Chemistry
Title:BiOCl Pro-Catalyzed Synthesis of Benzoxazepines from 4'-Hydroxy-3', 5'- Dinitro Substituted Chalcones and Ortho-Aminophenol
Volume: 11 Issue: 2
Author(s): K. L. Ameta
Affiliation:
Keywords: Benzoxazepines, pro-catalyst, chalcones, Michael addition.
Abstract: The present study describes the Bi (III) chloride catalyzed transformation of 4'-hydroxy-3',5'-dinitrochalcones into the corresponding benzoxazepines followed by sequential Michael addition using Bi (III) oxychloride as a procatalyst efficiently.
Export Options
About this article
Cite this article as:
Ameta L. K., BiOCl Pro-Catalyzed Synthesis of Benzoxazepines from 4'-Hydroxy-3', 5'- Dinitro Substituted Chalcones and Ortho-Aminophenol, Letters in Organic Chemistry 2014; 11 (2) . https://dx.doi.org/10.2174/1570178611310000090
DOI https://dx.doi.org/10.2174/1570178611310000090 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Therapeutic Strategies for Dementia
CNS & Neurological Disorders - Drug Targets Thromboembolic Complications in Malignant Haematological Disorders
Current Vascular Pharmacology The Role of Mast Cells in the Structural Alterations of the Airways as a Potential Mechanism in the Pathogenesis of Severe Asthma
Current Pharmaceutical Design Glioblastoma Tumor Initiating Cells: Therapeutic Strategies Targeting Apoptosis and MicroRNA Pathways
Current Molecular Medicine Nanocarriers for the Simultaneous Co-Delivery of Therapeutic Genes and Anticancer Drugs
Current Pharmaceutical Biotechnology Role of Imaging in Testicular Cancer
Current Medical Imaging The Endocrine Disruptor Bisphenol A (BPA) Exerts a Wide Range of Effects in Carcinogenesis and Response to Therapy
Current Molecular Pharmacology The Roles of miR-25 and its Targeted Genes in Development of Human Cancer
MicroRNA A Genetic Algorithm- Back Propagation Artificial Neural Network Model to Quantify the Affinity of Flavonoids Toward P-Glycoprotein
Combinatorial Chemistry & High Throughput Screening Drug Combinations in Breast Cancer Therapy
Pharmaceutical Nanotechnology Role of Forkhead Transcription Factors of the O Class (FoxO) in Development and Progression of Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Content Analysis, Cytotoxic, and Anti-metastasis Potential of Bioactive Polysaccharides from Green Alga <i>Codium intricatum</i> Okamura
Current Bioactive Compounds Revolutionary Impact of Nanodrug Delivery on Neuroscience
Current Neuropharmacology Computational Analysis of Drug Resistance Network in Lung Adenocarcinoma
Anti-Cancer Agents in Medicinal Chemistry Characteristic Alterations of Nuclear Structure and Chromatin Organisation of Cancer Cells Addressed by Proteome Analysis**
Current Proteomics Peptide-Based Nanostructures for Cancer Diagnosis and Therapy
Current Medicinal Chemistry SCYL1-BP1 Affects Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells via Cyclin F and RRM2
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Modulation of Gut Microbiota: Current Clinical Applications and Future Perspectives
Current Drug Targets Updated Review and Perspective on 20S Proteasome Inhibitors in the Treatment of Lung Cancer
Current Cancer Drug Targets The Role of LEF/TCF Factors in Neoplastic Transformation
Current Molecular Medicine